Articles about strengthening our immune system through the microbiome continue to be published. Below you will find yet another. The researchers conclude that their findings will help the pharmaceutical companies come up with a drug to fight COVID through the Microbiome. Did they think about good food optimizing our microbiome?
Researchers identify gut bacterium that inhibits SARS-CoV-2
Researchers from South Korea screened common gut bacteria for activity against SARS-CoV-2 and found a bacterium that produces compounds that inhibit the coronavirus, according to new findings presented at the virtual World Microbe Forum. “One of the interesting clinical findings is that some of the COVID-19 patients showed gastrointestinal symptoms, while others displayed stranded infection solely in the lung. If the bacteria that peacefully reside in our body without causing infection — called commensal microbes — might help in fighting the virus is still an open question to explore,” Mohammed Ali, a PhD student in medicine at Yonsei University in Seoul, told Healio. “In our work we found one bacterium, called Bifidobacterium, in which we observed such activity, and further experimental tests are going on,” Ali said. “Additionally, in the clinic, further research is also required to examine if fecal transplantation is helpful.” Ali and colleagues screened a total of 15 intestinal commensal bacteria for SARS-CoV-2 inhibiting abilities and found that Bifidobacterium — which can suppress other bacteria, including Heliobacter pylori — showed the strongest ability to suppress SARS-CoV-2 activity.”
